MFS Research International R2 holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
MFS Research International Fund Class R2 MRSRX
- NAV / 1-Day Return 27.46 / −0.65 %
- Total Assets 17.5B
-
Adj. Expense Ratio
1.240%
- Expense Ratio 1.240%
- Distribution Fee Level Below Average
- Share Class Type Retirement, Medium
- Category Foreign Large Blend
- Investment Style Large Blend
- Min. Initial Investment —
- Status Open
- TTM Yield 1.41%
- Turnover 27%
USD | NAV as of Jul 14, 2026 | 1-Day Return as of Jul 14, 2026, 12:11 AM GMT+0
Morningstar’s Analysis MRSRX
Will MRSRX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 22.2
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Mizuho Financial Group Inc | 2.84 | 503M | Financial Services |
Schneider Electric SE | 2.83 | 501M | Industrials |
Hitachi Ltd | 2.45 | 434M | Industrials |
ASML Holding NV | 2.22 | 393M | Technology |
Taiwan Semiconductor Manufacturing Co Ltd | 2.21 | 392M | Technology |
Novartis AG Registered Shares | 2.12 | 376M | Healthcare |
TotalEnergies SE | 2.10 | 373M | Energy |
Tokyo Electron Ltd | 1.90 | 337M | Technology |
AstraZeneca PLC | 1.78 | 316M | Healthcare |
Linde PLC | 1.76 | 313M | Basic Materials |